Gufic Biosciences receives TGA Australia and ANVISA Brazil approval for Parecoxib 40mg injection
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
The company will develop and produce premixes for human nutrition applications
With All India Institute of Ayurveda as a knowledge partner and Sodexo’s culinary expertise, Aarogyum is a well-rounded offering in patient dining solutions
Marking a significant milestone in its commitment to holistic wellness
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
Subscribe To Our Newsletter & Stay Updated